Regulations

A property memorandum links a Washington Avenue retail renovation to Trulieve TX Inc.; a Texas accessibility review does not authorize cannabis sales.

Saxony-Anhalt licensed new production areas in Leuna, but Aurora gave no tonnage or timetable for deliveries from the expanded site.

The live application separates medical marijuana manufacturers, distributors and labs; state licences remain a condition of registration.

The Oct. 5 rule caps adult-use edibles at 10 milligrams per serving and 100 milligrams per package; medical edibles have higher caps.

An Oct. 6 SEC amendment identifies a SEDAR+ notice changing the bid's consideration and expiry after Curaleaf announced new cash and share terms.

The Sept. 29 plan gives cannabis operators no deadline or estimate of tax relief as the guidance project enters the new fiscal year.

Congress delayed the new 0.4-milligram finished-product threshold to Dec. 11, leaving Tilray's disclosed U.S. drink formats above it.

State approvals cleared the Oct. 1 transfer of certain Ohio operations; AYR disclosed no cash proceeds or debt relief figure.

One petition is active and the other pending review; both would let Florida medical operators sell to adults if voters approve.

The ARTG's Sept. 15 entry names Jupiter Research as manufacturer; Curaleaf also reports a Sept. 17 New Zealand WAND notification.

Colorado completed its review on Sept. 29; permit issuance requires verified warranties, and DOE mine-plan approval remains pending.

A Sept. 29 stay in DEA hearing docket 26-96 sets Oct. 13 for a response to a motion seeking to add the GAO report to the record.

The perpetual, royalty-free agreement covers two brands, while a Texas launch still requires final state licensure and regulatory approval.

Curaleaf urged a signature on Sept. 23; A10698B would let regulators seek suspensions and impose daily civil penalties.

Aurora cites missing pro forma financials, a French-language notice and the mandatory 105-day deposit period in its ASC application.

Advisers voted 10 to 0 on safety and 6 to 4 on effectiveness; the FDA has not set a date for its final decision.

A 51 per cent stake in a Polish drone company remains a non-binding proposal, while the registered share sale is expected to close Sept. 24.

The Health Canada-authorized depression study plans to enroll up to 200 people, while the batch also serves Australian clinics.

Proposed legislation would stifle discussion on cannabis, psychedelics, and hemp products

Canada's cannabis exports at risk due to Israel's dumping investigation

Unanticipated setbacks include questions surrounding retail sales timeline

Bold move shakes up cannabis landscape worldwide

The first sale in the state's history was made at Housing Works Cannabis Co on Thursday

The federal fuel charge will apply to NL, NS and P.E.I. beginning in July next year

'Powering Past Coal' report is the result of 5 years of work from the Powering Past Coal Alliance comprised of governments worldwide

Cronos was charged with accounting misconduct in several reporting periods and improper bookkeeping for millions in revenue

Non-profit says Canada needs to make room for healthcare innovation with respect to psychedelic therapies

The report includes key findings to shape future directions for cannabis-related research, policy development and public health education

Country known for high-end automobiles, Oktoberfest and a strong economy may soon join countries who have legalized cannabis

Company undertakes new collaboration with Mission Green to initiate nationwide fundraising campaign

Proposed budget includes launching a new cannabis strategy table to increase dialogue between government and stakeholders

The public engagement will be available from April 6 until May 9 at 4 pm

The change will reduce some of the regulatory burdens for new and existing licence holders

Industry stakeholders have been extensively lobbying for this change